藥明生物
WuXi Biologics (Cayman) IncUSUSDWuXi Biologics (Cayman) Inc (HK:2269) — Biotechnology. Numărul de burse pe care se tranzacționează acțiunile companiei: 2. Pe această pagină — preț și grafic, dividende, principalii deținători și istoricul numărului de acțiuni.
Despre companie
- Site web
- wuxibiologics.com
- Sector
- Healthcare · Biotechnology
- Sediu central
- Wuxi, China
- Director general
- Zhisheng Chen
- Angajați
- 14 705
- Listată din
- 13.06.2017 (HK:2269)
- Acțiuni în circulație
- Free float
- 3.71 mld.
- Capitalizare de piață
- 221.69 mld. HKD
- Insideri
- 10.12%
- Investitori instituționali
- 36.36%
- Formă juridică
- OSBR
- ISIN
- KYG970081173
- LEI
- 5493001TD2TH6VDTJU11
Descriere
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Tumor Associated Antigens (TAA) mAb Technology, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; research and development in relation to biologics; international sales contracting service; vaccine contract development and manufacturing organization (CDMO) and related business; development, production, and distribution of biotechnological products; and engages in investment and material supplier activities. WuXi Biologics (Cayman) Inc. was incorporated in 2014 and is headquartered in Wuxi, China.
Știri din această săptămână
Comunicate de presă de pe site-ul investitorilor companiei, actualizate zilnic. Linkurile duc către site-ul companiei. Titlurile sunt în limba originală, ca pe site-ul companiei.
Cei mai mari acționari
| Deținător | Participație | Acțiuni | Data raportului |
|---|---|---|---|
| VANGUARD STAR FUNDS-Vang… | 1.34% | 55.13 mil. | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 1.27% | 52.41 mil. | 2026-07-31 |
| Chen (Zhisheng) (Chief E… | ≈1.19% | 49.19 mil. | 2026-09-11 |
| iShares, Inc.-iShares Co… | 0.97% | 40.12 mil. | 2026-08-31 |
| VANGUARD WORLD FUND-Vang… | 0.92% | 37.93 mil. | 2026-05-31 |
| American Century ETF Tru… | 0.27% | 11.01 mil. | 2026-08-31 |
| J.P. Morgan Exch-Trd Fd.… | 0.26% | 10.87 mil. | 2026-07-31 |
| VANGUARD Intl Eqy. INDEX… | 0.22% | 8.96 mil. | 2026-07-31 |
| iShares, Inc.-iShares MS… | 0.22% | 8.91 mil. | 2026-08-31 |
| Baird Funds Inc-Baird Ch… | 0.21% | 8.77 mil. | 2026-07-31 |
| iShares Trust-iShares MS… | 0.21% | 8.76 mil. | 2026-08-31 |
| Zhou (Weichang) (Chief T… | ≈0.14% | 5.6 mil. | 2025-06-02 |
| Gu (Xuejun Sherry) (Chie… | ≈0.03% | 1.37 mil. | 2026-08-24 |
| Boston Common Asset Mana… | 0.02% | 869 000 | 2024-03-31 |
| Li (Ge) (Chairman of the… | — | — | 2026-01-20 |
Conectează-te cu Google